Market revenue in 2023 | USD 329.2 million |
Market revenue in 2030 | USD 574.6 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.71% in 2023. Horizon Databook has segmented the Europe clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
The Europe clinical trial imaging market is driven by factors such as rapidly growing geriatric population and increasing prevalence of chronic diseases such as Parkinson’s, Huntington’s and Alzheimer's, which are driving the adoption of the clinical trial in this region.
Around 4,000 clinical trials of medicines are approved annually in the European Union (EU). Majority of these trials are conducted in Western European countries, but the number of clinical trials of medicines in this region is observed to be decreasing.
Applicability of Clinical Trial Regulation from 2019 has changed the experience of conducting clinical trial in the EU. The conduct of clinical trials in humans in the EU is regulated via Commission Directive 2001/20/EC and reinforced by Directive 2005/28/EC, laying down rules on Good Clinical Practice (GCP).
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe clinical trial imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Europe clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account